Back to Directory
Browse all EU alternatives
Origin-1
by Absci
AI Application
Low Confidence
Origin-1 is a generative AI platform for the de novo design of therapeutic antibodies targeting 'zero-prior' epitopes—sites with no previously known structural data or existing treatments
Transparency Score
Weighted across four pillars · updated May 18, 2026
Overall grade
29% weighted
Model
—
Not yet assessed
Infrastructure
—
Not yet assessed
Capabilities
Text Generation
Summarization
Translation
Conversation
Code Generation
Vendor Information
Complete information about the vendor/provider of this AI application
AbsciView all products →
Absci
Contact Information
Registered Address
18105 SE Mill Plain Blvd, Vancouver, Washington (WA), 98683, United States
EU AI Act Provider Information
Verification Status:
Partially Verified
Absci
18105 SE Mill Plain Blvd, Vancouver, Washington (WA), 98683, United States
Compliance Documents
CE Marking: Not Applicable
Compliance & Risk
Get insights into risk by running assessments on this AI application.
Work at Absci? Claim this listing to correct or complete the data.
Added: May 18, 2026
Updated: May 18, 2026
EU Alternatives
Discover EU-based alternatives for this AI application.
Alfie
Alfie
AI Application
AIR (AI by Revolut)
Revolut
AI Application
ClickMeeting AI
ClickMeeting
AI Application
Agion OS
Agion
AI Application
Ready to manage AI applications?
Track, assess, and govern your AI applications with Anove.